Who owns Aclaris Therapeutics?
- Ticker: ACRS
- CUSIP Number: 00461u105
Tip: Access positions for across all investors
Analyze quarterly positions in Aclaris Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aclaris Therapeutics stock
Who bought or sold Aclaris Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 14M | $43M | 0% | Dec 2025 |
|
| Vivo Capital | 8.9M | $27M | 0% | Dec 2025 |
|
| BlackRock | 6.8M | $21M | 20% | Dec 2025 |
|
| Vanguard Group | 6.5M | $20M | 0% | Dec 2025 |
|
| Adage Capital Partners GP | 5.3M | $10M | -45% | Sep 2025 |
|
| Rock Springs Capital Management | 4.5M | $13M | -3% | Dec 2025 |
|
| Decheng Capital | 4.0M | $12M | 0% | Dec 2025 |
|
| Geode Capital Management | 2.4M | $7.2M | 0% | Dec 2025 |
|
| D. E. Shaw & Co | 2.4M | $4.5M | -15% | Sep 2025 |
|
| Acadian Asset Management | 2.1M | $6.4M | -9% | Dec 2025 |
|
| Palo Alto Investors | 1.6M | $3.0M | 13% | Sep 2025 |
|
| Millennium Management | 1.6M | $3.0M | -59% | Sep 2025 |
|
| State Street Corporation | 1.5M | $4.5M | 35% | Dec 2025 |
|
| Connor, Clark & Lunn Investment Management | 1.4M | $4.3M | 34% | Dec 2025 |
|
| Citadel Advisors | 1.4M | $2.7M | 25% | Sep 2025 |
|
| Renaissance Technologies | 1.1M | $3.4M | -31% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 987k | $3.0M | 7% | Dec 2025 |
|
| Aldebaran Capital | 954k | $2.9M | -3% | Dec 2025 |
|
| Susquehanna International | 929k | $2.8M | 2464% | Dec 2025 |
|
| Bollard | 804k | $2.4M | -34% | Dec 2025 |
|
| Jpmorgan Chase & Co | 759k | $1.4M | 100% | Sep 2025 |
|
| Woodline Partners | 742k | $2.2M | 100% | Dec 2025 |
|
| Three Bridge Wealth Advisors | 715k | $2.2M | 0% | Dec 2025 |
|
| Northern Trust | 664k | $2.0M | -5% | Dec 2025 |
|
| Goldman Sachs Group | 633k | $1.9M | -34% | Dec 2025 |
|
| ADAR1 Capital Management | 614k | $1.8M | 64% | Dec 2025 |
|
| Logos Global Management | 600k | $1.8M | -60% | Dec 2025 |
|
| Marshall Wace | 486k | $1.5M | -72% | Dec 2025 |
|
| Qube Research & Technologies | 447k | $1.3M | -18% | Dec 2025 |
|
| Aisling Capital Management | 435k | $1.3M | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 393k | $747k | -11% | Sep 2025 |
|
| Two Sigma Investments | 368k | $699k | -51% | Sep 2025 |
|
| UBS Group | 363k | $1.1M | 245% | Dec 2025 |
|
| Two Sigma Advisers | 350k | $665k | -54% | Sep 2025 |
|
| Ameriprise Financial | 318k | $959k | -75% | Dec 2025 |
|
| HighTower Advisors | 306k | $921k | -1% | Dec 2025 |
|
| Charles Schwab Investment Management | 285k | $857k | 18% | Dec 2025 |
|
| Dimensional Fund Advisors | 271k | $815k | 65% | Dec 2025 |
|
| Raymond James Financial | 270k | $812k | -5% | Dec 2025 |
|
| Nuveen | 238k | $716k | 0% | Dec 2025 |
|
| Invesco | 210k | $632k | 29% | Dec 2025 |
|
| Bank of New York Mellon | 204k | $613k | -8% | Dec 2025 |
|
| Assenagon Asset Management | 155k | $465k | 0% | Dec 2025 |
|
| Barclays | 143k | $432k | 16% | Dec 2025 |
|
| XTX Topco | 113k | $340k | 77% | Dec 2025 |
|
| Seven Fleet Capital Management | 107k | $323k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 105k | $315k | 54% | Dec 2025 |
|
| ALPS Advisors | 89k | $268k | 100% | Dec 2025 |
|
| Point72 Asset Management | 87k | $262k | 100% | Dec 2025 |
|
| American Century Companies | 78k | $234k | 144% | Dec 2025 |
|
| Rhumbline Advisers | 72k | $216k | -21% | Dec 2025 |
|
| PanAgora Asset Management | 68k | $205k | 50% | Dec 2025 |
|
| Algert Coldiron Investors | 66k | $125k | 65% | Sep 2025 |
|
| Quadrature Capital | 58k | $174k | 100% | Dec 2025 |
|
| Creative Planning | 51k | $154k | 100% | Dec 2025 |
|
| Intech Investment Management | 47k | $140k | 20% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 43k | $128k | 0% | Dec 2025 |
|
| Man Group | 42k | $128k | 100% | Dec 2025 |
|
| Cambridge Investment Research Advisors | 42k | $126k | 0% | Dec 2025 |
|
| FMR | 40k | $77k | -91% | Sep 2025 |
|
| Susquehanna Portfolio Strategies | 40k | $120k | 100% | Dec 2025 |
|
| AQR Capital Management | 35k | $66k | 100% | Sep 2025 |
|
| Manufacturers Life Insurance Company | 29k | $87k | -13% | Dec 2025 |
|
| Royal Bank of Canada | 28k | $54k | 236% | Sep 2025 |
|
| Valeo Financial Advisors | 28k | $83k | 100% | Dec 2025 |
|
| New York State Common Retirement Fund | 27k | $82k | -44% | Dec 2025 |
|
| Jane Street | 27k | $82k | -63% | Dec 2025 |
|
| Vontobel Holding | 26k | $78k | 0% | Dec 2025 |
|
| MetLife Investment Advisors | 26k | $77k | -28% | Dec 2025 |
|
| Axq Capital | 24k | $73k | 73% | Dec 2025 |
|
| Persistent Asset Partners | 22k | $67k | 100% | Dec 2025 |
|
| ProShare Advisors | 22k | $65k | 45% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 22k | $65k | -19% | Dec 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 20k | $59k | 0% | Dec 2025 |
|
| Neuberger Berman Group | 19k | $57k | 49% | Dec 2025 |
|
| CRA Financial Services | 18k | $54k | 0% | Dec 2025 |
|
| China Universal Asset Management | 18k | $53k | 100% | Dec 2025 |
|
| CIBC Global Asset Management | 17k | $53k | 100% | Dec 2025 |
|
| Ing Investment Management | 17k | $52k | 0% | Dec 2025 |
|
| Mariner Wealth Advisors | 17k | $50k | 3% | Dec 2025 |
|
| Simplex Trading | 17k | $50k | 100% | Dec 2025 |
|
| SG Americas Securities | 15k | $46k | -30% | Dec 2025 |
|
| Alliancebernstein | 15k | $29k | 0% | Sep 2025 |
|
| Group One Trading | 12k | $37k | 611% | Dec 2025 |
|
| R Squared | 12k | $37k | 100% | Dec 2025 |
|
| Two Sigma Securities | 12k | $35k | 9% | Dec 2025 |
|
| Leucadia National Corporation | 11k | $33k | 0% | Dec 2025 |
|
| Victory Capital Management | 11k | $32k | 0% | Dec 2025 |
|
| Mercer Global Advisors | 10k | $31k | -3% | Dec 2025 |
|
| Russell Investments | 9.8k | $30k | 2% | Dec 2025 |
|
| Summit Investment Advisors | 9.3k | $28k | 0% | Dec 2025 |
|
| Legal & General Group | 8.2k | $25k | 0% | Dec 2025 |
|
| California State Teachers Retirement System | 5.6k | $17k | 0% | Dec 2025 |
|
| Sterling Capital Management | 5.3k | $16k | -12% | Dec 2025 |
|
| Mirae Asset Global Investments | 5.3k | $16k | 100% | Dec 2025 |
|
| Tower Research Capital | 3.8k | $11k | -42% | Dec 2025 |
|
| Amalgamated Bank | 2.9k | $9.0k | -7% | Dec 2025 |
|
| Gf Fund Management | 2.1k | $6.4k | 100% | Dec 2025 |
|
| Pnc Financial Services | 2.1k | $6.2k | 2% | Dec 2025 |
|
| Rockefeller Capital Management | 1.2k | $3.7k | 100% | Dec 2025 |
|
| Motiv8 Investments | 1.0k | $3.0k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 730.00 | $2.2k | 0% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 500.00 | $1.5k | 0% | Dec 2025 |
|
| EverSource Wealth Advisors | 458.00 | $1.4k | 0% | Dec 2025 |
|
| Capital Advisors | 454.00 | $999.980400 | 0% | Dec 2025 |
|
| Farther Finance Advisors | 398.00 | $1.2k | 302% | Dec 2025 |
|
| CWM | 380.00 | $1.0k | 38% | Dec 2025 |
|
| Smartleaf Asset Management | 376.00 | $1.1k | 100% | Dec 2025 |
|
| NISA Investment Advisors | 318.00 | $956.989200 | 0% | Dec 2025 |
|
| GAMMA Investing | 229.00 | $688.992300 | 100% | Dec 2025 |
|
| Truvestments Capital | 150.00 | $451.995000 | 0% | Dec 2025 |
|
| SBI Securities | 79.00 | $238.003300 | -67% | Dec 2025 |
|
| SRS Capital Advisors | 19.00 | $57.000000 | -96% | Dec 2025 |
|
| Rothschild Investment | 8.00 | $24.000000 | 100% | Dec 2025 |
|
Who sold out of Aclaris Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Stonepine Capital Management | Sep 2025 | 193k | $367k |
| Oxford Asset Management | Sep 2025 | 36k | $69k |
| Velan Capital Investment Management | Sep 2025 | 33k | $62k |
| Engineers Gate Manager | Sep 2025 | 18k | $34k |
| Cibc World Markets | Jun 2025 | 11k | $16k |